Correlation Between BriaCell Therapeutics and Inovio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BriaCell Therapeutics Corp and Inovio Pharmaceuticals, you can compare the effects of market volatilities on BriaCell Therapeutics and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Inovio Pharmaceuticals.

Diversification Opportunities for BriaCell Therapeutics and Inovio Pharmaceuticals

0.1

Correlation Coefficient

BriaCell Therapeutics  Inovio Pharmaceuticals

Average diversification

The 3 months correlation between BriaCell and Inovio is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Inovio Pharmaceuticals go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and Inovio Pharmaceuticals

Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to under-perform the Inovio Pharmaceuticals. In addition to that, BriaCell Therapeutics is 2.53 times more volatile than Inovio Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.09 per unit of volatility. If you would invest  219.00  in Inovio Pharmaceuticals on November 29, 2024 and sell it today you would lose (21.00) from holding Inovio Pharmaceuticals or give up 9.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

BriaCell Therapeutics Corp  vs.  Inovio Pharmaceuticals

BriaCell Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days BriaCell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Inovio Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with BriaCell Therapeutics and Inovio Pharmaceuticals

The main advantage of trading using opposite BriaCell Therapeutics and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.

The idea behind BriaCell Therapeutics Corp and Inovio Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.